• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 TNF 治疗阻断 T 细胞依赖性体液免疫应答的诱导。

Anti-TNF treatment blocks the induction of T cell-dependent humoral responses.

机构信息

Department of Clinical Immunology and Rheumatology, Academic Medical Centre/University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Ann Rheum Dis. 2013 Jun;72(6):1037-43. doi: 10.1136/annrheumdis-2011-201270. Epub 2012 Sep 11.

DOI:10.1136/annrheumdis-2011-201270
PMID:22968102
Abstract

OBJECTIVE

Experimental and human data suggest that tumour necrosis factor (TNF) blockade may affect B cell responses, in particular the induction of T cell-dependent (TD) humoral immunity. This study aimed to assess this hypothesis directly in patients with arthritis by analysing longitudinally the effect of TNF blockade on B cell activation and the maturation of humoral responses against TD and T cell-independent vaccines.

MATERIALS AND METHODS

Peripheral blood samples were obtained from 56 spondyloarthritis patients before and after treatment with either non-steroidal anti-inflammatory drug (NSAID) alone or TNF blockers and analysed for B cell activation, plasma cell differentiation, germinal centre versus extra-follicular B cell maturation, and somatic hypermutation. Vaccine responses to hepatitis B and Streptococcus pneumoniae were measured by ELISA.

RESULTS

TNF blockade augmented B cell activation as reflected by the expression of early activation markers, CD40, and costimulatory molecules, without affecting differentiation towards plasmablasts. This was associated with a specific increase of the unswitched fraction of circulating memory B cells and a decreased level of somatic hypermutation in anti-TNF treated patients, indicating an impairment of the germinal centre-dependent B cell maturation. In agreement with these findings, TNF blockade profoundly suppressed the response to the TD vaccination against hepatitis B, whereas the T cell-independent response against pneumococcal polysaccharides was only modestly affected.

CONCLUSIONS

These data indicate that TNF blockade severely impedes the induction of primary TD humoral responses, probably by interfering with the germinal centre reaction.

摘要

目的

实验和人体数据表明,肿瘤坏死因子(TNF)阻断可能会影响 B 细胞反应,特别是 T 细胞依赖性(TD)体液免疫的诱导。本研究旨在通过分析 TNF 阻断对关节炎患者 B 细胞激活和针对 TD 和 T 细胞非依赖性疫苗的体液反应成熟的长期影响,直接评估这一假设。

材料和方法

从 56 名脊柱关节炎患者中采集外周血样本,在单独使用非甾体抗炎药(NSAID)或 TNF 阻滞剂治疗前后进行分析,以评估 B 细胞激活、浆细胞分化、生发中心与滤泡外 B 细胞成熟以及体细胞超突变。通过 ELISA 测量乙型肝炎和肺炎球菌疫苗的反应。

结果

TNF 阻断增强了 B 细胞的激活,表现为早期激活标志物 CD40 和共刺激分子的表达增加,而不影响向浆母细胞的分化。这与循环记忆 B 细胞未转换部分的特异性增加以及抗 TNF 治疗患者体细胞超突变水平降低有关,表明生发中心依赖性 B 细胞成熟受损。与这些发现一致,TNF 阻断严重抑制了针对乙型肝炎的 TD 疫苗接种的反应,而针对肺炎球菌多糖的 T 细胞非依赖性反应仅受到适度影响。

结论

这些数据表明,TNF 阻断严重阻碍了原发性 TD 体液反应的诱导,可能是通过干扰生发中心反应。

相似文献

1
Anti-TNF treatment blocks the induction of T cell-dependent humoral responses.抗 TNF 治疗阻断 T 细胞依赖性体液免疫应答的诱导。
Ann Rheum Dis. 2013 Jun;72(6):1037-43. doi: 10.1136/annrheumdis-2011-201270. Epub 2012 Sep 11.
2
Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.类风湿关节炎患者接受抗肿瘤坏死因子治疗后,流感特异性 B 细胞反应下降。
Arthritis Res Ther. 2011;13(6):R209. doi: 10.1186/ar3542. Epub 2011 Dec 16.
3
Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.在管理式医疗人群中使用真实世界药物数据计算每名接受治疗患者的肿瘤坏死因子阻滞剂成本。
J Manag Care Pharm. 2013 Oct;19(8):621-30. doi: 10.18553/jmcp.2013.19.8.621.
4
Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study.肿瘤坏死因子阻滞剂对减少脊柱关节病患者葡萄膜炎发作的疗效:一项回顾性研究。
Ann Rheum Dis. 2006 Dec;65(12):1631-4. doi: 10.1136/ard.2006.052092. Epub 2006 Aug 10.
5
Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.肿瘤坏死因子α阻断治疗可下调脊柱关节病中Toll样受体2和Toll样受体4全身及局部表达的增加。
Arthritis Rheum. 2005 Jul;52(7):2146-58. doi: 10.1002/art.21155.
6
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.肿瘤坏死因子拮抗剂治疗诱导的银屑病皮损:临床特征及可能的免疫发病机制。
Semin Arthritis Rheum. 2010 Dec;40(3):233-40. doi: 10.1016/j.semarthrit.2010.04.003. Epub 2010 Jun 26.
7
The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept.是否存在针对英夫利昔单抗或阿达木单抗的抗体决定了转换为依那西普的结果。
Ann Rheum Dis. 2011 Feb;70(2):284-8. doi: 10.1136/ard.2010.135111. Epub 2010 Nov 10.
8
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.阿达木单抗、依那西普和英夫利昔单抗治疗强直性脊柱炎:系统评价与经济学评估
Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. doi: 10.3310/hta11280.
9
Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.肿瘤坏死因子治疗反应与 TLR 和 NF-κB 信号通路中遗传变异的相关性。
Ann Rheum Dis. 2010 Jul;69(7):1315-20. doi: 10.1136/ard.2009.117309. Epub 2010 May 6.
10
Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.肿瘤坏死因子-α(TNF-α)拮抗剂英夫利昔单抗、依那西普和阿达木单抗在合并类风湿性关节炎和乙型或丙型肝炎患者中的应用:11例患者的回顾性记录分析
Clin Rheumatol. 2009 Jul;28(7):787-91. doi: 10.1007/s10067-009-1149-4. Epub 2009 Mar 17.

引用本文的文献

1
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.肿瘤坏死因子抑制剂会影响mRNA疫苗接种后刺突特异性B细胞反应的诱导和维持。
RMD Open. 2025 Aug 4;11(3):e005724. doi: 10.1136/rmdopen-2025-005724.
2
Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel Disease.儿童炎症性肠病中SARS-CoV-2疫苗接种后12个月抗体反应的持久性
Vaccines (Basel). 2025 May 22;13(6):549. doi: 10.3390/vaccines13060549.
3
Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa.
联合靶向肿瘤坏死因子-α和OX40L作为化脓性汗腺炎的一种新治疗选择。
J Allergy Clin Immunol Glob. 2025 Apr 23;4(3):100483. doi: 10.1016/j.jacig.2025.100483. eCollection 2025 Aug.
4
Influenza vaccination in patients with juvenile idiopathic arthritis under different treatments: safety and immune response.不同治疗方案下幼年特发性关节炎患者的流感疫苗接种:安全性和免疫反应
Pediatr Rheumatol Online J. 2025 Apr 25;23(1):43. doi: 10.1186/s12969-025-01099-y.
5
Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients.免疫调节剂治疗的银屑病患者对BNT162b2疫苗的抗体反应。
J Psoriasis Psoriatic Arthritis. 2022 Jan;7(1):24-28. doi: 10.1177/24755303211056059. Epub 2021 Nov 12.
6
Secondary Immunodeficiency and Vaccine Response in Rheumatoid and Psoriatic Arthritis on Immunosuppressive Medicines.类风湿性关节炎和银屑病关节炎患者在接受免疫抑制药物治疗时的继发性免疫缺陷与疫苗反应
Cureus. 2024 Aug 7;16(8):e66366. doi: 10.7759/cureus.66366. eCollection 2024 Aug.
7
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination.抗TNF治疗会损害重复接种疫苗后的短期和长期IgG反应。
Allergy. 2025 Feb;80(2):423-439. doi: 10.1111/all.16241. Epub 2024 Jul 25.
8
Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine.COVID-19 感染时的银屑病和生物药物:概述感染风险、血清流行率以及 BNT162b2 疫苗安全性和有效性的小型综述。
Front Immunol. 2024 Jan 30;15:1354729. doi: 10.3389/fimmu.2024.1354729. eCollection 2024.
9
Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers.使用原研或生物类似药阿达木单抗治疗对SARS-CoV-2疫苗接种抗体滴度的影响。
Int J Pharm X. 2024 Jan 6;7:100229. doi: 10.1016/j.ijpx.2024.100229. eCollection 2024 Jun.
10
Hepatitis B vaccination associated with low response in patients with rheumatic diseases treated with biologics.乙型肝炎疫苗接种与接受生物制剂治疗的风湿性疾病患者低应答相关。
RMD Open. 2023 Dec 6;9(4):e003597. doi: 10.1136/rmdopen-2023-003597.